HENLIUS(02696),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02696 HENLIUS

Market Closed 09-04 16:08:03

70.100

+1.050

+1.52%

High71.050	Low68.300	Vol881.56K
Open69.950	D1 Closing69.050	Amplitude3.98%
Mkt Cap38.20B	Tradable Cap24.39B	Total Shares545.00M
T/O61.83M	T/O Rate0.25%	Tradable Shares348.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02696","market":"HK","secType":"STK","nameCN":"HENLIUS","latestPrice":70.1,"timestamp":1788509283006,"preClose":69.05,"halted":0,"volume":881557,"delay":0,"changeRate":0.015206372194062233,"floatShares":348000000,"shares":545000000,"eps":1.7643752843467013,"marketStatus":"Market Closed","change":1.05,"latestTime":"09-04 16:08:03","open":69.95,"high":71.05,"low":68.3,"amount":61825140,"amplitude":0.039826,"askPrice":70.2,"askSize":8800,"bidPrice":70.1,"bidSize":6300,"shortable":3,"etf":0,"ttmEps":1.8460234185032738,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788744600000},"marketStatusCode":7,"adr":0,"listingDate":1569340800000,"exchange":"SEHK","adjPreClose":69.05,"openAndCloseTimeList":[[1788485400000,1788494400000],[1788498000000,1788508800000]],"volumeRatio":1.0754325362381418,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02696","defaultTab":"news","newsList":[{"id":"1117043556","title":"Henlius CEO Zhu Jun: AI Will Evolve from a Productivity Tool into a Transformative Catalyst for Drug Discovery","url":"https://stock-news.laohu8.com/highlight/detail?id=1117043556","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117043556?lang=en_us&edition=fundamental","pubTime":"2026-09-05 23:00","pubTimestamp":1788620428,"startTime":"0","endTime":"0","summary":"At the 2026 Yabuli Forum Summer Annual Meeting held in Chengdu from September 4-6, a key conversation unfolded regarding the future of pharmaceutical innovation. Dr. Zhu Jun, Executive Director and...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTY","HK0000306701.USD","QTOC","HK0000306685.HKD","CHAT","HK0000320264.USD","VTHR","02696","BK1161","HK0000320223.HKD","HK0000165453.HKD","AIPO","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158783895","title":"AI Integration Becomes Essential for Biopharma's Future, Says Henlius CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=1158783895","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158783895?lang=en_us&edition=fundamental","pubTime":"2026-09-05 14:20","pubTimestamp":1788589217,"startTime":"0","endTime":"0","summary":"At the 2026 Yabuli Forum Summer Annual Meeting, held from September 4-6 in Chengdu, Sichuan, Zhu Jun, CEO of HENLIUS, stated that the primary mission of the healthcare industry is to help people live...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","03069","BBP","HK0000306685.HKD","AGIX","02696","01477","ARTY","HK0000320223.HKD","VTHR","BK1161","QTOC","CHAT","HK0000165453.HKD","AIPO","BK1191","HK0000306701.USD","MRNX","HK0000320264.USD","MRNY","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664813811","title":"Shanghai Henlius Biotech (SEHK:2696) Reports Strong Half Year Growth, Is It Overvalued?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664813811","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664813811?lang=en_us&edition=fundamental","pubTime":"2026-09-02 15:26","pubTimestamp":1788333964,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech (SEHK:2696) drew fresh attention after reporting half year 2026 sales of CNY 3,588.23 million and net income of CNY 430.44 million, alongside a new Hong Kong principal business address.\nShanghai Henlius Biotech’s recent half year update has come alongside a strong shift in market sentiment, with a 22.55% 1 month share price return and a 16.38% year to date share price return, even though the 1 year total shareholder return declined 11.43%.\nSpot fresh momentum in...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/shanghai-henlius-biotech-sehk2696-reports-strong-half-year-g","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/shanghai-henlius-biotech-sehk2696-reports-strong-half-year-g","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HK0000320223.HKD","BK4588","DCF","HK0000306701.USD","XBI","HK0000165453.HKD","HK0000306685.HKD","HK0000320264.USD","BK4585","BK1161","BK4581","02696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130168137","title":"HENLIUS Surges Nearly 7% in Morning Trade on Strong Overseas Revenue Growth and Citi's Upgraded Forecasts","url":"https://stock-news.laohu8.com/highlight/detail?id=1130168137","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130168137?lang=en_us&edition=fundamental","pubTime":"2026-08-27 10:20","pubTimestamp":1787797214,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) climbed nearly 7% in early trading on the Hong Kong Stock Exchange, last up 5.86% at HK$72.3, with turnover reaching HK$14.17 million.The biopharmaceutical company released its...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203345920.USD","LU0098860793.USD","HK0000165453.HKD","HK0000306701.USD","LU0162691827.USD","LU1074936037.SGD","LU1506573853.SGD","LU2236285917.USD","LU0130517989.USD","LU1244550494.USD","BK4585","LU0128525689.USD","LU0648001328.SGD","BK4207","LU1201861249.SGD","BK4588","LU1791807156.HKD","LU0203347892.USD","02696","LU0310800965.SGD","LU1244550221.USD","LU2456880835.USD","VXUS","LU2125154778.USD","LU2360032135.SGD","TFNS","BK4566","LU0320765646.SGD","LU0052756011.USD","LU0106831901.USD","LU1244550577.SGD","LU1267930227.SGD","HK0000306685.HKD","BK1161","HK0000320264.USD","LU2417539215.USD","FTXO","KCAI","LU1144417596.USD","HK0000320223.HKD","LU0477156953.USD","LU0314106906.USD","LU1162221912.USD","LU1668664300.SGD","LU2462157665.USD","BK4559","LU0980610538.SGD","LU2125154935.USD","BK4534","C","IE00BSNM7G36.USD","LU0170899867.USD","BK4504","IYF","LU0130102774.USD","LU0072461881.USD","LU1366192091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102078176","title":"Global Industry Company Boosts Stake in HENLIUS with HK$15.94 Million Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1102078176","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102078176?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:40","pubTimestamp":1787748036,"startTime":"0","endTime":"0","summary":"Latest data from the Stock Exchange of Hong Kong reveals that on August 21, Global Industry Company increased its holdings in HENLIUS (02696) by 232,200 shares at an average price of HK$68.6666 per...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696","GIC","HK0000320223.HKD","HK0000306685.HKD","EWH","BK1161","BK4104","HK0000320264.USD","HK0000306701.USD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195026878","title":"HENLIUS: GIC Private Limited Acquires Shares, Long Position Rises to 5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=1195026878","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195026878?lang=en_us&edition=fundamental","pubTime":"2026-08-26 17:12","pubTimestamp":1787735546,"startTime":"0","endTime":"0","summary":"On August 21, 2026, GIC Private Limited bought 232,200 shares of HENLIUS (H shares) at an average of HKD 68.6666 per share, involving about HKD 15.94 million.Prior to the acquisition, GIC Private...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152296334","title":"Citi Lifts HENLIUS Price Target to HK$95.2, Reaffirms 'Buy' on Solid H1 Organic Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1152296334","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152296334?lang=en_us&edition=fundamental","pubTime":"2026-08-26 15:18","pubTimestamp":1787728696,"startTime":"0","endTime":"0","summary":"Citi has released a research report indicating that HENLIUS (02696) delivered solid organic growth in the first half of 2026, with revenue reaching RMB 3.59 billion, up 27% year-on-year, and net...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0170899867.USD","LU0310800965.SGD","LU1506573853.SGD","LU0098860793.USD","LU1244550494.USD","LU2236285917.USD","BK4207","BK4534","HK0000320264.USD","C","LU0130517989.USD","LU0052756011.USD","LU0477156953.USD","LU2125154778.USD","HK0000306701.USD","LU1201861249.SGD","LU1791807156.HKD","TFNS","LU0980610538.SGD","LU0320765646.SGD","LU0162691827.USD","02696","LU1668664300.SGD","LU1162221912.USD","HK0000306685.HKD","LU0203345920.USD","BK4559","LU0203347892.USD","LU1244550221.USD","BK4588","LU1074936037.SGD","HK0000320223.HKD","LU0314106906.USD","LU1144417596.USD","LU2417539215.USD","LU2462157665.USD","LU0072461881.USD","BK4504","BK4585","LU1267930227.SGD","LU0106831901.USD","LU2456880835.USD","EWH","LU0648001328.SGD","LU1366192091.USD","IYF","LU0128525689.USD","LU2125154935.USD","LU0130102774.USD","LU1244550577.SGD","BK1161","BK4566","IE00BSNM7G36.USD","LU2360032135.SGD","FTXO","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662760576","title":"Sweden's Alligator Bioscience Q2 Loss Widens, no Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2662760576","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662760576?lang=en_us&edition=fundamental","pubTime":"2026-08-26 14:09","pubTimestamp":1787724578,"startTime":"0","endTime":"0","summary":"Sweden's Alligator Bioscience Q2 loss widens, no salesOverviewSweden biotech firm reported no Q2 net sales and a wider net loss yr/yrCompany discontinued mitazalimab development to focus on HLX22 roya","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N06E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696","HK0000320264.USD","BK1230","HK0000165453.HKD","HK0000306685.HKD","BK1161","HK0000320223.HKD","HK0000306701.USD","00656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662760533","title":"Alligator Bioscience Q2 FY26 Operating Loss Widens to SEK 36.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662760533","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662760533?lang=en_us&edition=fundamental","pubTime":"2026-08-26 14:07","pubTimestamp":1787724442,"startTime":"0","endTime":"0","summary":"Alligator Bioscience Q2 FY26 operating loss widens to SEK 36.2 millionAlligator Bioscience posted a Q2 operating loss of SEK 36.2 million, widening from SEK 22.3 million a year earlier.Net loss widene","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL3sY0z8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1230","BK1161","02696","HK0000306701.USD","HK0000320264.USD","00656","HK0000165453.HKD","HK0000306685.HKD","HK0000320223.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662735875","title":"Shanghai Henlius Files HKEX Next-Day Disclosure Return, Lifts Share Capital by 26,600 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2662735875","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662735875?lang=en_us&edition=fundamental","pubTime":"2026-08-25 18:24","pubTimestamp":1787653495,"startTime":"0","endTime":"0","summary":"Shanghai Henlius files HKEX next-day disclosure return, lifts share capital by 26,600 sharesShanghai Henlius Biotech filed a next-day disclosure return with Hong Kong Exchange on Aug. 25, 2026.Issued ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDL67brcM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000306701.USD","HK0000165453.HKD","BK1161","HK0000320223.HKD","HK0000320264.USD","BK1230","02696","00656","HK0000306685.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198484647","title":"Southbound Trading Access Approaches: HENLIUS Posts RMB3.588B Revenue and RMB430.4M Net Profit in Interim Results, Reinforcing Growth Sustainability","url":"https://stock-news.laohu8.com/highlight/detail?id=1198484647","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198484647?lang=en_us&edition=fundamental","pubTime":"2026-08-25 11:18","pubTimestamp":1787627929,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) released its 2026 interim results on August 21, showcasing a high-quality, steadily growing revenue and profit performance. During the reporting period, the company achieved revenue...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000320223.HKD","HK0000306685.HKD","02696","HK0000320264.USD","FLHK","HK0000165453.HKD","BK1161","HK0000306701.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661512275","title":"Chinese Drugmaker Wuxi XDC's First-Half Revenue Rises on Project Expansion, Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2661512275","media":"Reuters","labels":["corporation","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661512275?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:34","pubTimestamp":1787571262,"startTime":"0","endTime":"0","summary":"Chinese drugmaker Wuxi XDC's first-half revenue rises on project expansion, acquisitionOverviewChina bioconjugate CRDMO's H1 2026 revenue grew 37% yr/yr to RMB3.7 blnAdjusted net profit for H1 2026 ro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL1N44L0D5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1610","LU0326950275.SGD","HK0000306701.USD","02269","LU0588546209.SGD","LU1720050803.USD","LU0359202008.SGD","LU0856984785.SGD","HK0000320223.HKD","LU1242518857.USD","02696","BK1141","LU1880383366.USD","BK1576","LU1242518931.SGD","LU0039217434.USD","LU0348735423.USD","LU0456827905.SGD","LU0320764599.SGD","SG9999002562.SGD","LU0516422440.USD","BK1521","BK1589","LU0140636845.USD","BK1230","IE00B0JY6N72.USD","LU0708995583.HKD","SG9999014674.SGD","KURE","LU0029874061.USD","LU0456846285.SGD","LU0516423091.SGD","688428","LU0051755006.USD","LU0327786744.USD","LU0052750758.USD","00656","LU0359201612.USD","LU0417516902.SGD","LU0572944931.SGD","LU2488822045.USD","LU0348825331.USD","LU3063872942.SGD","LU2039709279.SGD","BK1161","LU1688375341.USD","LU1794554557.SGD","LU0819121731.USD","HK0000306685.HKD","02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661227355","title":"China's InnoCare Pharma H1 Revenue Surges, Partly on Orelabrutinib Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2661227355","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661227355?lang=en_us&edition=fundamental","pubTime":"2026-08-24 17:44","pubTimestamp":1787564642,"startTime":"0","endTime":"0","summary":"China's InnoCare Pharma H1 revenue surges, partly on orelabrutinib growthOverviewChina biopharmaceutical firm's H1 revenue grew 55.5% yr/yr, driven by drug sales and collaborationsAdjusted net income ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL1N44L0AM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000306685.HKD","BK1583","BK4139","09969","BK0239","BK1574","BK1230","BK1191","HK0000165453.HKD","HK0000306701.USD","HK0000320264.USD","ZBIO","00656","06996","HK0000320223.HKD","02696","688428","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191983584","title":"HENLIUS Posts Strong First-Half Results and Secures Hang Seng Composite Index Membership","url":"https://stock-news.laohu8.com/highlight/detail?id=1191983584","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191983584?lang=en_us&edition=fundamental","pubTime":"2026-08-24 11:01","pubTimestamp":1787540495,"startTime":"0","endTime":"0","summary":"HENLIUS (02696.HK) has reported a robust financial performance for the first half of fiscal year 2026, marked by simultaneous growth in both revenue and net profit. During the reporting period, the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000320264.USD","HK0000320223.HKD","BK1161","HK0000165453.HKD","HSCI","02696","HK0000306685.HKD","HK0000306701.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661241804","title":"Sinopharm Interim Revenue Edges Down on Softness in Pharmaceutical Distribution Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2661241804","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661241804?lang=en_us&edition=fundamental","pubTime":"2026-08-24 08:02","pubTimestamp":1787529767,"startTime":"0","endTime":"0","summary":"Sinopharm interim revenue edges down on softness in pharmaceutical distribution businessOverviewChina pharmaceutical distributor's interim revenue declined slightly year-on-yearNet income attributable","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL1N44K04V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696","02137","BK1515","BK1197","LU0640798160.USD","BK1230","BK1161","HK0000306685.HKD","HK0000320223.HKD","BK1574","EDMCQ","HK0000306701.USD","LU1115378108.SGD","BK4204","HK0000320264.USD","BK1500","01099","BK1587","00656","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661298705","title":"Henlius Reports 2026 Interim Results: Sustained Profitability Leap, Advancing Global Value Validation, and Accelerating Progress Towards C-Mnc","url":"https://stock-news.laohu8.com/highlight/detail?id=2661298705","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661298705?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:59","pubTimestamp":1787317160,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nTUA5MKK6D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000306701.USD","HK0000165453.HKD","BK1161","HK0000320223.HKD","HK0000320264.USD","02696","HK0000306685.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109544200","title":"Henlius Reports 27.3% Revenue Growth and Higher Profit on Robust Product Sales and Global Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1109544200","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109544200?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:08","pubTimestamp":1787314107,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech, Inc. released unaudited 1H 2026 results showing revenue of RMB 3.59 billion, up 27.30% year on year (1H 2025: RMB 2.82 billion). Drug sales, R&D services and licence income...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Henlius Reports 27.3% Revenue Growth and Higher Profit on Robust Product Sales and Global Expansion","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180617623","title":"Henlius Added to Hang Seng Composite Index, Eligible for Stock Connect from 7 September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1180617623","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180617623?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:07","pubTimestamp":1787314032,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech, Inc. (Henlius) disclosed on 21 August 2026 that the company will be included in the Hang Seng Composite Index following the index provider’s quarterly review for the period...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661267726","title":"Shanghai Henlius Biotech Logs HY Profit RMB 430.4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2661267726","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661267726?lang=en_us&edition=fundamental","pubTime":"2026-08-21 19:39","pubTimestamp":1787312395,"startTime":"0","endTime":"0","summary":"Aug 21 (Reuters) - Shanghai Henlius Biotech HY profit RMB430.4 million:((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))Source Date/Time = 21-AUG-202611:27:33.923 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nRSD8g8f0p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696","HK0000165453.HKD","HK0000306701.USD","BK1161","HK0000320264.USD","HK0000320223.HKD","BK1230","HK0000306685.HKD","00656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150636167","title":"HENLIUS Secures Spot in Hang Seng Composite Index","url":"https://stock-news.laohu8.com/highlight/detail?id=1150636167","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150636167?lang=en_us&edition=fundamental","pubTime":"2026-08-21 19:38","pubTimestamp":1787312297,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) has announced its inclusion as a constituent stock of the Hang Seng Composite Index, following the quarterly index review results released by Hang Seng Indexes Company Limited on...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000306685.HKD","BK1161","HK0000320264.USD","HSCI","02696","HK0000165453.HKD","HK0000320223.HKD","HK0000306701.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0007},{"period":"1month","weight":0.1162},{"period":"3month","weight":0.1645},{"period":"6month","weight":0.0159},{"period":"1year","weight":-0.0728},{"period":"ytd","weight":0.2287}],"compareEarnings":[{"period":"1week","weight":0.0026},{"period":"1month","weight":-0.0102},{"period":"3month","weight":0.0276},{"period":"6month","weight":-0.0041},{"period":"1year","weight":0.0236},{"period":"ytd","weight":0.0008}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Shanghai Henlius Biotech Inc is a China-based company principally engaged in biopharmaceutical research and development, biopharmaceutical services and biopharmaceutical production and sales. The Company’s main products include HANQUYOU (trastuzumab for injection), HANNAIJIA (neratinib maleate), HANSIZHUANG (serplulimab injection), HANLIKANG (rituximab injection), HANDAYUAN (adalimumab injection), HANBEITAI (bevacizumab injection) and others. The Company’s products are mainly used in the treatment of adjuvant breast cancer, metastatic breast cancer, metastatic gastric cancer, metastatic non-squamous non-small cell lung cancer, polyarticular juvenile idiopathic arthritis and others. The Company mainly operates its businesses in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.044394},{"month":2,"riseRate":0.714286,"avgChangeRate":0.117695},{"month":3,"riseRate":0.571429,"avgChangeRate":-0.008815},{"month":4,"riseRate":0.857143,"avgChangeRate":0.12138},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.033714},{"month":6,"riseRate":0.571429,"avgChangeRate":0.085211},{"month":7,"riseRate":0.428571,"avgChangeRate":0.040127},{"month":8,"riseRate":0.571429,"avgChangeRate":0.005816},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.100355},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.025526},{"month":11,"riseRate":0.571429,"avgChangeRate":0.058675},{"month":12,"riseRate":0.714286,"avgChangeRate":-0.023816}],"exchange":"SEHK","name":"HENLIUS","nameEN":"HENLIUS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"HENLIUS(02696),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest HENLIUS(02696) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"HENLIUS,02696,HENLIUS股票,HENLIUS股票老虎,HENLIUS股票老虎国际,HENLIUS行情,HENLIUS股票行情,HENLIUS股价,HENLIUS股市,HENLIUS股票价格,HENLIUS股票交易,HENLIUS股票购买,HENLIUS股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"HENLIUS(02696),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest HENLIUS(02696) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}